Celldex Therapeutics Inc (NASDAQ:CLDX)

0.6872
Delayed Data
As of Apr 23
 -0.0129 / -1.84%
Today’s Change
0.65
Today|||52-Week Range
3.42
-75.80%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +1,209.66% increase from the last price of 0.69.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$1.5M
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -633.33%
 
 
 
 
 
 
Growthannually -1.94%
 
 
 
 
 
 

Sales

Growthquarterly -56.60%
 
 
 
 
 
 
Growthannually 54.34%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.